Standardization of the Italian ALS-CBS™ Caregiver Behavioral Questionnaire

Background The present investigation aimed at testing the psychometrics and diagnostics of the Italian version of the Caregiver Behavioral Questionnaire (CBQ) from the ALS Cognitive Behavioral Screen (ALS-CBS™), as well as its case–control discrimination, in a cohort of non-demented patients with ALS. Methods The caregivers of N = 265 non-demented patients with ALS and N = 99 healthy controls (HCs) were administered the CBQ and the Edinburgh Cognitive and Behavioural ALS Screen-Carer Interview (ECAS-CI). For N = 98 patients, an in-depth behavioural/psychopathological assessment via the Frontal Behavioural Inventory (FBI), the Dimensional Apathy Scale (DAS), the State and Trait Anxiety Inventory-Form Y (STAI-Y), and the Beck Depression Inventory (BDI) was also available. Factorial and construct validity, internal reliability, and diagnostics against an abnormal ECAS-CI score were tested in patients. Case–control discrimination was explored through logistic regression. Results The CBQ was internally reliable (McDonald’s ω = 0.90) and underpinned by a simple, unidimensional structure; it converged with ECAS-CI, FBI, and DAS scores and diverged from STAI-Y and BDI ones. A cutoff of ≤ 33 accurately detected abnormal ECAS-CI scores (AUC = 0.85), yielding optimal error- and information-based diagnostics. The CBQ was independent of demographic and disease-related variables and discriminated patients from HCs (p < 0.001). Discussion The Italian version of the CBQ from the ALS-CBS™ is a valid, reliable, diagnostically sound, and feasible screener for detecting frontotemporal-like behavioural changes in non-demented patients with ALS. Its adoption is thus recommended within clinical practice and research in the view of providing preliminary information on whether the administration of more extensive behavioural instruments is needed.

[1]  R. Ferrucci,et al.  Diagnostic properties of the Italian ECAS Carer Interview (ECAS-CI) , 2022, Neurological Sciences.

[2]  Stephen A. Goutman,et al.  Amyotrophic lateral sclerosis , 2022, The Lancet.

[3]  N. Bolognini,et al.  Psychometrics, diagnostics and usability of Italian tools assessing behavioural and functional outcomes in neurological, geriatric and psychiatric disorders: a systematic review , 2022, Neurological Sciences.

[4]  S. Abrahams,et al.  International evaluation of current practices in cognitive assessment for motor neurone disease , 2022, British Journal of Neuroscience Nursing.

[5]  M. Filippi,et al.  A preliminary comparison between ECAS and ALS-CBS in classifying cognitive–behavioural phenotypes in a cohort of non-demented amyotrophic lateral sclerosis patients , 2021, Journal of Neurology.

[6]  A. Chiò,et al.  Italian adaptation of the Beaumont Behavioral Inventory (BBI): psychometric properties and clinical usability , 2021, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[7]  Monica Consonni,et al.  Cognitive and behavioural impairment in amyotrophic lateral sclerosis: A landmark of the disease? A mini review of longitudinal studies , 2021, Neuroscience Letters.

[8]  S. Chandran,et al.  A systematic review of neuropsychiatric and cognitive assessments used in clinical trials for amyotrophic lateral sclerosis , 2020, Journal of Neurology.

[9]  M. V. van Es,et al.  An overview of screening instruments for cognition and behavior in patients with ALS: selecting the appropriate tool for clinical practice , 2020, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[10]  Colin J. Mahoney,et al.  The impact of cognitive and behavioral impairment in amyotrophic lateral sclerosis , 2020, Expert review of neurotherapeutics.

[11]  M. Filippi,et al.  ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability , 2019, Neurological Sciences.

[12]  L. Goldstein,et al.  Screening for cognitive and behavioral change in amyotrophic lateral sclerosis/motor neuron disease: a systematic review of validated screening methods , 2018, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[13]  R. Goetz,et al.  Longitudinal Screening Detects Cognitive Stability and Behavioral Deterioration in ALS Patients , 2018, Behavioural neurology.

[14]  Theodoros A. Kyriazos,et al.  Applied Psychometrics: Sample Size and Sample Power Considerations in Factor Analysis (EFA, CFA) and SEM in General , 2018 .

[15]  T. Hortobágyi,et al.  Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria , 2017, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[16]  S. Cuoco,et al.  Assessment of apathy independent of physical disability: validation of the Dimensional Apathy Scale in Italian healthy sample , 2017, Neurological Sciences.

[17]  F. Madotto,et al.  The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS) , 2016, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[18]  Gokmen Zararsiz,et al.  easyROC: An Interactive Web-tool for ROC Curve Analysis Using R Language Environment , 2016, R J..

[19]  Hae-Young Kim Statistical notes for clinical researchers: assessing normal distribution (2) using skewness and kurtosis , 2013, Restorative dentistry & endodontics.

[20]  A. Thompson,et al.  What sample sizes for reliability and validity studies in neurology? , 2012, Journal of Neurology.

[21]  Nick C Fox,et al.  Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. , 2011, Brain : a journal of neurology.

[22]  B. Miller,et al.  Classification of primary progressive aphasia and its variants , 2011, Neurology.

[23]  M. York,et al.  Detecting frontotemporal dysfunction in ALS: Utility of the ALS Cognitive Behavioral Screen (ALS-CBS™) , 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[24]  P. Bossuyt Clinical validity: Defining biomarker performance , 2010, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[25]  A. Kertesz,et al.  The Frontal Behavioural Inventory (Italian version) differentiates frontotemporal lobar degeneration variants from Alzheimer's disease , 2007, Neurological Sciences.

[26]  M. Swash,et al.  El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[27]  J. Cedarbaum,et al.  The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function , 1999, Journal of the Neurological Sciences.

[28]  福田 博一 State-Trait Anxiety Inventoryによるペインクリニック外来患者の不安の評価 , 1994 .

[29]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.